Monte Rosa Therapeutics (GLUE) Pension (2020 - 2026)

Monte Rosa Therapeutics' Pension history runs 7 years deep, the most recent figure standing at $5.3 million for Q1 2026.

• In Q1 2026, Pension rose 32.79% year-over-year to $5.3 million; the TTM figure through Mar 2026 stood at $5.3 million (up 32.79% YoY), while the FY2025 annual figure was $5.3 million, up 42.22% from the prior year.
• Pension was $5.3 million for Q1 2026 at Monte Rosa Therapeutics, roughly flat from $5.3 million in the prior quarter.
• In the past five years, Pension ranged from a high of $12.0 million in Q4 2023 to a low of $1.5 million in Q3 2023.
• Historically, Pension has averaged $3.8 million across 5 years, with a median of $2.8 million in 2024.
• Biggest YoY gain for Pension was 94.29% in 2024; the steepest drop was 69.22% in 2024.
• A 5-year view of Pension shows it stood at $6.9 million in 2022, then soared by 75.58% to $12.0 million in 2023, then slumped by 69.22% to $3.7 million in 2024, then surged by 42.22% to $5.3 million in 2025, then declined by 0.09% to $5.3 million in 2026.
• The last three Pension figures came in at $5.3 million (Q1 2026), $5.3 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.